Algotec introduces ImagiNet Lite

Article

Low-volume imaging facilities are the intended beneficiaries of Algotec's Web-based PACS product called ImagiNet Lite. The product, launched at SCAR, is designed for freestanding clinics, small centers, and hospitals that perform fewer than 75,000

Low-volume imaging facilities are the intended beneficiaries of Algotec's Web-based PACS product called ImagiNet Lite. The product, launched at SCAR, is designed for freestanding clinics, small centers, and hospitals that perform fewer than 75,000 procedures annually. With a sticker price of under $100,000, the new product is intended to appeal to smaller practices with limited budgets, according to the company. The product is based on the same software as Algotec's standard ImagiNet PACS. It is scalable to grow with an institution as imaging volume increases, and is compatible with other information systems, such as patient scheduling and radiology information systems.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.